HiFIT Study: Interest of Intravenous Iron and Tranexamic Acid to Reduce Transfusion in Hip Fracture Patients
Latest Information Update: 04 Aug 2022
At a glance
- Drugs Ferric derisomaltose (Primary) ; Tranexamic acid (Primary)
- Indications Anaemia; Hip fracture
- Focus Therapeutic Use
- Acronyms HiFIT
- 16 Oct 2021 Status changed from active, no longer recruiting to discontinued.
- 09 Jul 2021 Planned End Date changed from 1 Oct 2022 to 1 Oct 2021.
- 09 Jul 2021 Planned primary completion date changed from 1 Oct 2022 to 1 Oct 2021.